Expert Ratings for Definitive Healthcare
Portfolio Pulse from Benzinga Insights
Definitive Healthcare (NASDAQ:DH) has received various analyst ratings in the last quarter, with 2 bullish, 2 somewhat bullish, and 2 indifferent ratings. The average 12-month price target for the company is $12.08, representing an 18.93% decrease from the previous average price target of $14.90.
November 03, 2023 | 1:00 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Definitive Healthcare has received mixed analyst ratings, with an average 12-month price target of $12.08, a decrease from the previous target.
The decrease in the average 12-month price target for Definitive Healthcare indicates a bearish outlook from analysts, which could negatively impact the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100